par 867 (Dronabinol 2.5 mg)
Pill imprint par 867 has been identified as Dronabinol 2.5 mg.
Dronabinol is used in the treatment of nausea/vomiting, chemotherapy induced; post traumatic stress disorder; anorexia; aids related wasting and belongs to the drug class miscellaneous antiemetics. Risk cannot be ruled out during pregnancy. Dronabinol 2.5 mg is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- par 867
- Strength:
- 2.5 mg
- Color:
- White
- Size:
- 12.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antiemetics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 3 - Moderate abuse potential
- Manufacturer:
- Par Pharmaceutical Inc.
- National Drug Code (NDC):
- 49884-0867
- Inactive Ingredients:
- FD&C Yellow No. 6
gelatin
glycerin
water
sesame oil
titanium dioxide
FD&C Blue No. 1
FD&C Red No. 40
ferrosoferric oxide
shellac
isopropyl alcohol
butyl alcohol
propylene glycol
ammonia
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68084-0174 | Amerisource Health Services |
Note: Inactive ingredients may vary.
More about dronabinol
Consumer resources
- Other brands: Marinol
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
